Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» reimbursement
reimbursement
In 2 years, insurers must disclose what they pay for prescription drugs
In 2 years, insurers must disclose what they pay for prescription drugs
Beckers Hospital Review
regulatory
insurers
reimbursement
Flag link:
Good News for COVID-19 Testing Companies: Medicare Nearly Doubles Reimbursement
Good News for COVID-19 Testing Companies: Medicare Nearly Doubles Reimbursement
Motley Fool
CMS
Medicare
diagnostics
COVID-19
reimbursement
Flag link:
New Antibiotics Face Major Development And Reimbursement Hurdles
New Antibiotics Face Major Development And Reimbursement Hurdles
Forbes
antibiotic resistance
antibiotics
drug-resistant infections
drug development
reimbursement
Flag link:
Pharma's gene and cell therapy ambitions will kick into high gear in 2020—despite some major hurdles
Pharma's gene and cell therapy ambitions will kick into high gear in 2020—despite some major hurdles
Fierce Pharma
gene therapy
reimbursement
drug manufacturing
Bristol-Myers Squibb
Pfizer
Biomarin
Sarepta Therapeutics
Gilead Sciences
CAR-T
Flag link:
Drugs firms make massive discounts to get reimbursement in China
Drugs firms make massive discounts to get reimbursement in China
Pharmaforum
Roche
Novartis
China
reimbursement
Flag link:
How Medical Billing Coverage Spells Success Or Failure For Drugmakers
How Medical Billing Coverage Spells Success Or Failure For Drugmakers
Motley Fool
reimbursement
R&D
Medicare
Flag link:
Senate, White House hoping for deal to restructure Medicare drug payments
Senate, White House hoping for deal to restructure Medicare drug payments
BioCentury
Senate
Medicare
reimbursement
Flag link:
Medicare proposes raising CAR-T pay, but reimbursement solution years away
Medicare proposes raising CAR-T pay, but reimbursement solution years away
Biopharma Dive
CMS
CAR-T
Medicare
reimbursement
Flag link:
ICER's Growing Impact On Drug Pricing And Reimbursement
ICER's Growing Impact On Drug Pricing And Reimbursement
Forbes
ICER
drug pricing
reimbursement
Flag link:
China proposes 50% reimbursement for chronic disease therapies
China proposes 50% reimbursement for chronic disease therapies
BioCentury
China
reimbursement
chronic disease
Flag link:
What Will Keep Medtech up at Night in 2019?
What Will Keep Medtech up at Night in 2019?
Medical Devices and Diagnostics Industry
devices
taxes
cybersecurity
reimbursement
trade
technology
regulatory
patients
physicians
Flag link:
Hospital docs weigh in on CAR-T reimbursement: 'It's very complicated'
Hospital docs weigh in on CAR-T reimbursement: 'It's very complicated'
BioSpace
CAR-T
hospitals
reimbursement
Flag link:
CMS rule cuts reimbursement for new Part B drugs
CMS rule cuts reimbursement for new Part B drugs
BioCentury
Medicare Part B
CMS
reimbursement
physician-administered drugs
Flag link:
Reimbursement lags cancer drug approvals, but some European countries wait longer
Reimbursement lags cancer drug approvals, but some European countries wait longer
Biopharma Dive
Europe
drug approvals
reimbursement
Flag link:
Better U.S. Patient Access To Cancer Drugs Comes At A Price
Better U.S. Patient Access To Cancer Drugs Comes At A Price
Forbes
cancer
Europe
patient access
patients
reimbursement
drug pricing
Flag link:
Medicare sets outpatient rate for Yescarta reimbursement
Medicare sets outpatient rate for Yescarta reimbursement
Reuters
Medicare
Yescarta
reimbursement
Gilead Sciences
Flag link:
Medical device reimbursement: How it’s a brave new world
Medical device reimbursement: How it’s a brave new world
Medical Design and Outsourcing
devices
reimbursement
Flag link:
Reimbursement Trends for Medical Devices in Japan
Reimbursement Trends for Medical Devices in Japan
Medical Devices and Diagnostics Industry
devices
Japan
reimbursement
Flag link:
Medical Device Reimbursement in the US
Medical Device Reimbursement in the US
RAPS.org
devices
reimbursement
Flag link:
Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars
Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars
Drug Channels
drug pricing
reimbursement
Remicade
biosimilars
Janssen
Inflectra
Pfizer
Renflexis
Merck
Flag link:
Pages
1
2
next ›
last »